Clinical Trial

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.
Trial Details
NCT Number NCT06788418
Lead Sponsor Beijing Visionly Plus Eye Hospital
Collaborators: High Myopia Control Alliance (HIMALAYA), Beijing New Vision Eye Hospital, Shanghai Parkway Hospital
Conditions Myopia
Enrollment 1,000 participants
Start Date 2025-01-20
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-23